Jan 28, 2021
In 2020, COVID-19 dominated the headlines and much of the focus for people who work in biotechnology. While the global pandemic continues, there is hope in the vaccines currently being distributed throughout the world. At the same time, seasonal influenza remains a concern.
On a new episode of the World of Promise podcast, Dave Ross, Vice President, Commercial Operations North America, for Seqirus, discusses how his organization’s expertise in influenza vaccines could help with the distribution and immunization practices necessary to combat COVID-19. He also shares additional insights from his team’s work with influenza and how it relates to the COVID-19 pandemic.